Currently, Longevity Health Holdings Inc [XAGE] is trading at $2.64, down -1.31%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XAGE shares have gain 12.55% over the last week, with a monthly amount drifted -0.19%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
This stock has fluctuated between a low of $2.20 and a high of $59.10 over the last 52 weeks. Longevity Health Holdings Inc [NASDAQ: XAGE] shares were valued at $2.64 at the most recent close of the market.
Analyzing the XAGE fundamentals
Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at -9.14%, Pretax Profit Margin comes in at -15.52%, and Net Profit Margin reading is -15.34%. To continue investigating profitability, this company’s Return on Assets is posted at -2.58, Equity is 2.47 and Total Capital is 1.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.60 points at the first support level, and at 2.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.70, and for the 2nd resistance point, it is at 2.75.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Longevity Health Holdings Inc [NASDAQ:XAGE] is 0.42. As well, the Quick Ratio is 0.21, while the Cash Ratio is 0.12. Considering the valuation of this stock, the price to sales ratio is 4.75.
Transactions by insiders
Recent insider trading involved Upton Richard A, Director, that happened on Sep 13 ’24 when 5000.0 shares were purchased. Director, Gregory Kathryn completed a deal on Sep 06 ’24 to buy 1260.0 shares. Meanwhile, Director Sturgeon Patrick A bought 1261.0 shares on Sep 06 ’24.
